Crossref journal-article
American Society for Microbiology
Infection and Immunity (235)
Abstract

ABSTRACTHuman macrophages are hosts forMycobacterium tuberculosis, the causative agent of tuberculosis, which killed approximately 1.87 million people in 1997. Human alveolar macrophages do not express α- or β-defensins, broad-spectrum antimicrobial peptides which are expressed in macrophages from other species more resistant to infection withM. tuberculosis. It has been previously reported thatM. tuberculosisis susceptible to killing by defensins, which may explain the difference in resistance. Defensin peptides have been suggested as a possible therapeutic strategy for a variety of infectious diseases, but development has been hampered by difficulties in their large-scale production. Here we report the cellular synthesis of human β-defensin 2 via highly efficient mRNA transfection of human macrophages. This enabled mycobactericidal and mycobacteristatic activity by the macrophages. Although human macrophages are difficult to transfect with plasmid vectors, these studies illustrate that primary macrophages are permissive for mRNA transfection, which enabled expression of a potentially therapeutic protein.

Bibliography

Kisich, K. O., Heifets, L., Higgins, M., & Diamond, G. (2001). Antimycobacterial Agent Based on mRNA Encoding Human β-Defensin 2 Enables Primary Macrophages To Restrict Growth ofMycobacterium tuberculosis. Infection and Immunity, 69(4), 2692–2699.

Authors 4
  1. Kevin O. Kisich (first)
  2. Leonid Heifets (additional)
  3. Michael Higgins (additional)
  4. Gill Diamond (additional)
References 34 Referenced 68
  1. 10.1093/nar/22.23.4963
  2. 10.1084/jem.184.4.1349
  3. 10.1128/IAI.67.7.3267-3275.1999
  4. 10.1128/iai.62.6.2375-2378.1994
  5. 10.1046/j.1365-2958.1999.01279.x
  6. 10.1006/clin.1998.4587
  7. 10.1073/pnas.93.10.5156
  8. 10.1073/pnas.88.9.3952
  9. 10.1128/iai.50.1.1-8.1985
  10. 10.1001/jama.282.7.677
  11. 10.1006/bmme.1996.0080
  12. Ganz T. and R. I. Lehrer. 1995. Defensins: pharmacology and therapeutics. 66: 191–205. (10.1016/0163-7258(94)00076-F)
  13. 10.1038/43088
  14. 10.1016/0076-6879(94)36015-4
  15. 10.1016/S0021-9258(17)42145-4
  16. 10.1089/oli.1.1996.6.111
  17. Kisich K. O. Malone R. W. Feldstein P. A. Erickson K. L. Specific inhibition of macrophage TNF-alpha expression by in vivo ribozyme treatment.J. Immunol.163199920082016 (10.4049/jimmunol.163.4.2008) / J. Immunol. / Specific inhibition of macrophage TNF-alpha expression by in vivo ribozyme treatment by Kisich K. O. (1999)
  18. 10.1016/S0965-1748(98)00101-5
  19. 10.1182/blood.V68.6.1407.1407
  20. 10.1073/pnas.86.16.6077
  21. 10.1128/iai.64.3.926-932.1996
  22. 10.1128/AAC.40.6.1482
  23. 10.1128/iai.60.11.4720-4725.1992
  24. Ouellette A. J. IV. Paneth cell antimicrobial peptides and the biology of the mucosal barrier.Am. J. Physiol.2771999G257G261 / Am. J. Physiol. / IV. Paneth cell antimicrobial peptides and the biology of the mucosal barrier by Ouellette A. J. (1999)
  25. 10.1096/fasebj.10.11.8836041
  26. 10.1128/iai.31.2.723-731.1981
  27. Quayle A. J. Martin Porter E. Nussbaum A. A. Wang Y.-M. Brabec C. Mok S. C. Gene expression, immunolocalization and secretion of human defensin-5 in human female genital tract.Am. J. Pathol.152199812471258 / Am. J. Pathol. / Gene expression, immunolocalization and secretion of human defensin-5 in human female genital tract by Quayle A. J. (1998)
  28. 10.1128/IAI.66.2.878-881.1998
  29. 10.1002/jlb.65.2.270
  30. 10.1165/ajrcmb.20.5.3572
  31. Valore E. V. Ganz T. Laboratory production of antimicrobial peptides in native conformation.Methods Mol. Biol.781997115131 / Methods Mol. Biol. / Laboratory production of antimicrobial peptides in native conformation by Valore E. V. (1997)
  32. 10.1038/sj.gt.3300626
  33. 10.1006/cimm.1993.1098
  34. 10.1074/jbc.274.37.26249
Dates
Type When
Created 23 years, 1 month ago (July 27, 2002, 6:01 a.m.)
Deposited 2 years, 4 months ago (April 23, 2023, 11:31 a.m.)
Indexed 5 months ago (March 27, 2025, 4:59 p.m.)
Issued 24 years, 4 months ago (April 1, 2001)
Published 24 years, 4 months ago (April 1, 2001)
Published Print 24 years, 4 months ago (April 1, 2001)
Funders 0

None

@article{Kisich_2001, title={Antimycobacterial Agent Based on mRNA Encoding Human β-Defensin 2 Enables Primary Macrophages To Restrict Growth ofMycobacterium tuberculosis}, volume={69}, ISSN={1098-5522}, url={http://dx.doi.org/10.1128/iai.69.4.2692-2699.2001}, DOI={10.1128/iai.69.4.2692-2699.2001}, number={4}, journal={Infection and Immunity}, publisher={American Society for Microbiology}, author={Kisich, Kevin O. and Heifets, Leonid and Higgins, Michael and Diamond, Gill}, editor={Kozel, T. R.}, year={2001}, month=apr, pages={2692–2699} }